Literature DB >> 6485706

Analysis of immunoreactive and biologically active human parathyroid hormone-peptides by high-performance-liquid-chromatography.

T Schettler, B Aufm' Kolk, M J Atkinson, H Radeke, C Enters, R D Hesch.   

Abstract

A combination of high-performance-liquid-chromatography (HPLC), sensitive radioimmunoassays and a homologous in vitro bioassay was used to characterise human parathyroid hormone (hPTH)-peptides in human parathyroid adenoma and plasma. Chromatography of several synthetic hPTH-peptides allows the calibration of the HPLC column. On the basis of sequence hydrophobicity the elution position of peptides can be predicted. A model for the determination of the minimal peptide sequence of each peptide has been developed which based on immunological and physico-chemical properties allows the characterisation of unknown hPTH-peptides. Using this technique the heterogeneity of circulating hPTH-peptides in human plasma has been examined. Plasma extracts from healthy individuals, osteoporotic, hyperparathyroid and pseudo-hyperparathyroid patients were investigated. A uniform pattern in the heterogeneity of hPTH-peptides was detected. Using parathyroid adenoma as reference disease specific changes were characterised.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6485706     DOI: 10.1530/acta.0.1070060

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  Storage and degradation of secretory proteins in adenomatous and secondary hyperplastic parathyroid cells. An immunoelectron microscope study.

Authors:  G Berger; F Berger; F Billard; J Danowski; J L Vauzelle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  [Morphologic changes in iliac crest trabecular bone in primary hyperparathyroidism and their significance for diagnosis].

Authors:  G Delling; T Dreyer; R D Hesch; W Schulz; R Ziegler; M Bressel
Journal:  Klin Wochenschr       Date:  1987-07-15

3.  Parathyroid hormone in coronary artery disease--results of a prospective study.

Authors:  G Herrmann; R Hehrmann; H C Scholz; M Atkinson; P Lichtlen; A von zur Mühlen; R D Hesch
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.